Skip to main content
Caplight Logo









Platomics

Platomics

Private
ViennaHealthcare & Life Scienceshttps://platomics.com/

Last Round

Series A

Sep 20, 2021

Total Funding Raised

$16.38M

Company Overview

Platomics is a healthtech company that provides a platform for regulatory automation for in vitro diagnostics, connecting manufacturers, labs, and regulators.

Sector

Healthcare & Life Sciences

Verticals

RegTech, Compliance, Vertical SaaS, Workflow Automation, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

regulatory automationIVDR compliancein-vitro diagnosticsIVDRegTechcompliance automationIn Vitro Diagnostic RegulationIVDRlab-developed testsLDTsregulatory documentationMedTech complianceclinical laboratory softwareVertical SaaSworkflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Platomics Comparables

Compare Platomics with similar companies based on industry and business-model similarity.

Platomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MedStrato
78%
RegDesk
73%
OpenRegulatory
72%

Platomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 20, 2021

Key People

Founding team and executive leadership

Kriegner Albert

CEO

Executive Team

Rodrigo Berlie

CEO and Managing Director

Executive Team

Felix Kamml

Chief Financial Officer

Executive Team

Piotr Gawel

Chief Operating Officer

Executive Team

Platomics Investors

Notable investors and investment history

Platomics investors
InvestorRounds
GreyBird VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 14, 2023

    Grew 17% QoQ, from 70 to 82 employees.

  • Nov 3, 2023

    Grew 19% QoQ, from 67 to 80 employees.

Platomics Filings

Explore SEC and related filing metadata, where available.

Platomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Platomics's valuation, stock price, and market status.

Is Platomics a public or private company?

Platomics is a private company.

What is the current stock price of Platomics?

Platomics is a private company with no public stock price. No recent secondary market data is available.

How much is Platomics worth (valuation)?

Valuation information for Platomics is not publicly available.

Can I buy Platomics stock?

Platomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Platomics's last funding round?

Funding round information for Platomics is not publicly available.

Who are the main investors in Platomics?

Investor information for Platomics is not publicly disclosed.

Will Platomics IPO soon?

No public IPO plans have been announced for Platomics.

How can I track Platomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Platomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range51
Year Founded2014
Last FundingSep 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?